KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Assets (2016 - 2025)

Neogenomics' Non-Current Assets history spans 16 years, with the latest figure at $983.5 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 5.61% year-over-year to $983.5 million; the TTM value through Dec 2025 reached $983.5 million, down 5.61%, while the annual FY2025 figure was $983.5 million, 5.61% down from the prior year.
  • Non-Current Assets reached $983.5 million in Q4 2025 per NEO's latest filing, down from $992.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.2 billion in Q3 2021 to a low of $551.7 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: skyrocketed 123.09% in 2021, then fell 5.61% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $1.2 billion in 2021, then dropped by 4.5% to $1.1 billion in 2022, then decreased by 4.44% to $1.1 billion in 2023, then decreased by 3.91% to $1.0 billion in 2024, then fell by 5.61% to $983.5 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Non-Current Assets are $983.5 million (Q4 2025), $992.3 million (Q3 2025), and $1.0 billion (Q2 2025).